With regard to body size, while Mapk3 can change obesity‐related parameters such as adipogenesis and adiposity in mice, there is conflicting evidence on whether Mapk3 loss of function increases [58] or decreases obesity [59, 60]. Here, MAPK3 is linked to obesity due to melanocortin 4 receptor deficiency.